Clinical trial
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants
NCT00407082 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00407082 |
|---|---|
| Title | Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants |
| Official title | A Multicenter, Randomized, Double-Masked, Controlled Study to Evaluate the Safety & Efficacy of Intravitreal Fluocinolone Acetonide (0.59 or 2.1 mg) Implant in Subjects With Non-Infectious Uveitis Affecting the Posterior Segment of the Eye |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Noninfectious Posterior Uveitis |
| Intervention type | Drug |
| Interventions | fluocinolone acetonide intravitreal implant, Fluocinolone acetonide 2.1mg |
| Enrollment | 278 |
| Start date | Dec 1, 2000 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Dec 4, 2006 |
| Last update posted | Dec 8, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: